Comparative analysis of HPV DNA and LBC for screening of cervical cancer in women with unhealthy cervix
Background: The cervical cancer is one of the leading cause of cancer death among women in developing and developed countries. Screening for cervical cancer is essential as the women are often asymptomatic and it also reduces both the incidence and mortality of the cancer cervix if detected in early...
Main Authors: | Shreya Raj, Mala Srivastava |
---|---|
Format: | Article |
Language: | English |
Published: |
Barpeta Obstetrics and Gynaecological Society
2022-02-01
|
Series: | New Indian Journal of OBGYN |
Subjects: | |
Online Access: | https://journal.barpetaogs.co.in/pdf/08166.pdf |
Similar Items
-
Guidelines for HPV-DNA Testing for Cervical Cancer Screening in Brazil
by: Luiz Carlos Zeferino, et al.
Published: (2018-06-01) -
Evaluating the economic screening of cervical cancer using IVA, HPV DNA, and histology methods: Systematic review
by: Ana Rofika, et al.
Published: (2023-11-01) -
Clinical validation of high risk HPV DNA testing versus ThinPrep cytology for primary cervical cancer screening
by: Mahmoud El-Morsi Aboul-Fotouh, et al.
Published: (2013-06-01) -
HPV-specific risk assessment of cervical cytological abnormalities
by: Guanglei Zhong, et al.
Published: (2021-08-01) -
The Value of TruScreen (An Artificial Intelligence Cervical Cancer Screening System) in High-Risk HPV Positive Patients
by: Lianmei Luo, et al.
Published: (2023-10-01)